panda
Bendectin and birth defects
Products liability
Abnormalities, human
Human Abnormalities
Legislation
Toxicology
Adverse effects
Drugs
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilitie…
Not available to read online
This scan is restricted to patrons with print disabilities and can't be borrowed with a regular free account — signing up won't unlock it. Try Toronto Public Library, Libby, or Amazon above instead.
